The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment

BACKGROUND: Cancer and anti-cancer treatment (ACT) may be risk factors for severe SARS-CoV-2 infection and limited vaccine efficacy. Long–term longitudinal studies are needed to evaluate these risks. The Scottish COVID cancer immunity prevalence (SCCAMP) study characterizes the incidence and outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Purshouse, Karin, Thomson, John P, Vallet, Mahéva, Alexander, Lorna, Bonisteel, Isaac, Brennan, Maree, Cameron, David A, Figueroa, Jonine D, Furrie, Elizabeth, Haig, Pamela, Heck, Mattea, McCaughan, Hugh, Mitchell, Paul, McVicars, Heather, Primrose, Lorraine, Silva, Ines, Templeton, Kate, Wilson, Natalie, Hall, Peter S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
European Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020811/
https://www.ncbi.nlm.nih.gov/pubmed/36719033
http://dx.doi.org/10.1093/oncolo/oyac257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020811/
https://www.ncbi.nlm.nih.gov/pubmed/36719033
http://dx.doi.org/10.1093/oncolo/oyac257

Ejemplares similares